ABSTRACT
Background The sociodemographic predictors of either out-of-pocket expenditure (OOP) or underinsurance among skin cancer survivors is not well reported in the literature. In this study we estimated all-cause healthcare related OOP expenditure and probability of underinsurance among insured skin cancer survivors and identified the sociodemographic predictors of these measures.
Data and Method We pooled Medical Expenditure Panel Survey (MEPS) data from 2011 to 2015 and identified skin cancer using Clinical Classifications Software (CCS) code. Only adult (≥18 years) skin cancer survivors with full year insurance coverage were included in our study (n = 1825). We used a generalized linear model (GLM) with log link and gamma distribution to estimate OOP and a logit model to estimate the probability of underinsurance. We estimated the Average Marginal Effect (AME) to quantify the variations and their statistical significance between reference level and other levels of each predictor. Our analyses accounted for the complex survey design of MEPS.
Results The average all-cause OOP was $1766 per person per year for a skin cancer survivor. Among all skin cancer survivors, females, those aged 60-64 years, with some college education or a degree, with income ≥400% of federal poverty level (FPL) and with non-managed-care private insurance incurred significantly higher OOP expenditure compared to their respective counterparts. In terms of underinsurance, females and those aged 60-64 years had higher probability, whereas, survivors with non-white race/ethnicity and income 200% of FPL or higher had lower probability of being underinsured compared to their respective counterparts.
Conclusion Our study demonstrates that OOP expenditure and underinsurance varies significantly by sociodemographic factors among skin cancer survivors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was conducted with support in part by the Population Informatics Lab, Department of Health Policy and Management, School of Public Health, Texas A&M University and Texas Virtual Data Library (ViDaL) funded by the Texas A&M University Research Development Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted using publicly available survey datasets.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: This work was conducted with support in part by the Population Informatics Lab, Department of Health Policy and Management, School of Public Health, Texas A&M University and Texas Virtual Data Library (ViDaL) funded by the Texas A&M University Research Development Fund.
Conflict of interest/Financial disclosures/Disclaimers: The authors disclose no conflicts.
Data availability statement: Data was obtained from the resources available in the public domain: https://meps.ahrq.gov/data_stats/download_data_files.jsp
Data Availability
Data used in this study is available from Agency for Healthcare Research and Quality (AHRQ) - Medical Expenditure Panel Survey (MEPS) website.
